Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Artemisia argyi folium extract** is an extract derived from the leaves of *Artemisia argyi* (Chinese mugwort), a traditional Chinese medicinal plant. Historically, it is used in Traditional Chinese Medicine (TCM) for managing inflammatory conditions, infections, and menstrual symptoms, as well as in the practice of moxibustion. Its pharmacological properties include anti-inflammatory, antimicrobial, antifungal, antioxidant, and antitumor activities. Primary bioactive compounds include flavones (such as eupatilin and jaceosidin), terpenoids, and volatile oils. The extract is also used in functional foods and health products for supporting immune function and improving gastrointestinal health. Mechanistic studies suggest modulation of immune response, antimicrobial effects, and inhibition of inflammatory pathways, though evidence is mainly from in vitro and animal studies[2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artemisia argyi folium extract.